|
advertisement
|
news roundup
Medidata, a Dassault Systèmes company, announced that CRO Medpace will integrate Medidata’s Rave Imaging with Medpace's imaging systems and workflow. This will create a platform for capturing, managing, analyzing and storing images and imaging data for clinical trials.
WCG has announced that The Michael J. Fox Foundation for Parkinson’s Research (MJFF) is introducing a redesigned version of its Fox Trial Finder clinical study matching tool powered by WCG CenterWatch iConnect’s advanced trial listing technology. The platform will aim to make it easier for people with Parkinson’s disease and healthy volunteers to both find and participate in clinical trials.
CRO Synteract has launched the Synteract Rare Disease Institute, a program that incorporates lectures, webinars, interactive discussions, videos, and industry literature to provide its employees a foundation in rare disease drug development, as well as an understanding of this growing area of clinical research.
|
|
|
advertisement
Virtual, Decentralized, Site-less Trials… What Does it All Mean?
Thursday, March 12, 2020 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
Register now
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
advertisement
Advances in RBM Drive the Clinical Trial of the Future
Access an online resource with useful tools and practical information about advances in RBM. The site provides useful white papers, articles, webcasts, and more.
Access all resources
|
|
|
|
|
|
|
|
|
|
Articles |
|
In this article, the authors present research to determine whether medicines currently being licensed are including sufficient elderly patients to meet the needs of the ever-ageing global population. |
In this article, the author provides a case study of Merz Pharma’s approach to RBQM process integration, using Cyntegrity’s professional program.
|
Blog Posts
In this opinion, the author lists new approaches to data that prioritize its function and operational abilities.
|
|
 |
|
|
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
|
